TGM1
Gene therapyexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2019 (NCT04047732)
Timeline
Indications
Mechanism of action
- Protein-glutamine gamma-glutamyltransferase KSupplementation
TGM1 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05735158 | Phase 2 | Mar 31, 2023 | Krystal Biotech, Inc. |
| NCT04047732 | Phase 1/Phase 2 (Phase 2) | Sep 30, 2019 | Krystal Biotech, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Krystal Biotech, Inc. | For profit | 2 | 2 | 1 | 2019 |
1 organizations
Page 1 / 1